Quantify.
Intervene.
Measure.
The longevity industry is saturated with marketing. We evaluate clinics, diagnostics, and interventions based on human clinical data, hard endpoints, and verifiable outcomes.
No supplements, no lifestyle coaching. We track epigenetic clocks, rapamycin protocols, and the tier-1 clinics executing them.
State of the Industry (2024)
- Clinics Tracked: 42 verified
- Current Standard: DunedinPACE clock
- Average Cost/Year: $25,000 - $120,000
- Leading Intervention: mTOR inhibition
Directory Index
Compare Clinics
Analyze top-tier longevity clinics by diagnostic capabilities, physician background, and annual membership costs.
Biological Age Tests
Not all clocks are equal. Compare 1st, 2nd, and 3rd generation epigenetic clocks for accuracy and responsivity to interventions.
Interventions
Deep dives into pharmaceutical and cellular therapies actively prescribed off-label for aging.
Diagnostic Minimums
Before initiating any longevity protocol, a baseline must be established. We consider the following the absolute minimum diagnostic stack for a tier-1 longevity clinic in 2024.
| Modality | Target Assay / Scan | Rationale |
|---|---|---|
| Imaging | Whole-Body MRI (w/ Diffusion) | Early stage solid tumor detection (Stage 1 detection rate ~92%). |
| Cardiovascular | Cleerly CCTA or AI-guided Angiography | Quantifies soft vs calcified plaque volume (superior to standard CAC score). |
| Genomic | Whole Genome Sequencing (30x depth) | Identifies monogenic risk variants (APOE4, BRCA, Lp(a) predisposition). |
| Biomarkers | ApoB, Lp(a), hs-CRP, Fasting Insulin | Standard metabolic and lipid panel driving 80% of preventable mortality. |